Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$820M |
| 2 |
Palo Alto Networks
PANW
|
+$358M |
| 3 |
Visa
V
|
+$355M |
| 4 |
CELG
Celgene Corp
CELG
|
+$339M |
| 5 |
Citigroup
C
|
+$325M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$722M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$356M |
| 3 |
Alibaba
BABA
|
+$345M |
| 4 |
EOG Resources
EOG
|
+$344M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.08% |
| 2 | Consumer Discretionary | 17.25% |
| 3 | Communication Services | 14.3% |
| 4 | Technology | 13.13% |
| 5 | Financials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Kosmos Energy
KOS
$1.6B
| $14.6M | 0.02% |
2,616,231
+36,749
| +1% | +$255K |
|
|
B
477
DELISTED
Barnes Group Inc.
B
| $14.3M | 0.01% |
+397,807
| New | +$15.2M |
|
|
PRTY
478
DELISTED
Party City Holdco Inc.
PRTY
| $14.2M | 0.01% |
891,933
+465,692
| +109% | +$8.76M |
|
479
PUT
iShares US Healthcare ETF
IYH
$3.37B
| $14.2M | 0.01% |
+505,890
| New | +$15.8M |
|
480
ProQR Therapeutics
PRQR
$243M
| $14.1M | 0.01% |
968,755
+2,322
| +0.2% | +$38.9K |
|
|
PKY
481
DELISTED
Parkway, Inc.
PKY
| $14.1M | 0.01% |
907,159
-161,648
| -15% | -$2.73M |
|
|
NUVA
482
DELISTED
NuVasive, Inc.
NUVA
| $14.1M | 0.01% |
291,832
+283,201
| +3,281% | +$14.6M |
|
|
DTEA
483
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
| $13.6M | 0.01% |
866,967
+193,103
| +29% | +$3.07M |
|
|
ABGB
484
DELISTED
Abengoa SA Class B
ABGB
| $13.5M | 0.01% |
2,899,020
-40,598
| -1% | -$343K |
|
|
ICD
485
DELISTED
Independence Contract Drilling, Inc.
ICD
| $13.4M | 0.01% |
134,763
+705
| +0.5% | +$96.3K |
|
486
Lumentum
LITE
$55.5B
| $13.3M | 0.01% |
+787,566
| New | +$14.9M |
|
|
FEIC
487
DELISTED
FEI COMPANY
FEIC
| $12.9M | 0.01% |
177,071
+48
| +0% | +$3.78K |
|
488
Natera
NTRA
$38.3B
| $12.3M | 0.01% |
+1,143,532
| New | +$19.4M |
|
489
Caesarstone
CSTE
$72.3M
| $12.2M | 0.01% |
400,712
-8,101
| -2% | -$423K |
|
|
ESRX
490
CALL
DELISTED
Express Scripts Holding Company
ESRX
| $12.1M | 0.01% |
150,000
| – | – |
|
|
CHS
491
DELISTED
Chicos FAS, Inc.
CHS
| $12M | 0.01% |
763,613
-1,703,365
| -69% | -$26.4M |
|
|
AVDL
492
DELISTED
Avadel Pharmaceuticals
AVDL
| $11.9M | 0.01% |
726,586
+5,626
| +0.8% | +$124K |
|
|
BLOX
493
DELISTED
Infoblox Inc
BLOX
| $11.8M | 0.01% |
739,010
+145,291
| +24% | +$3.17M |
|
|
FLOW
494
DELISTED
SPX FLOW, Inc.
FLOW
| $11.8M | 0.01% |
+341,647
| New | +$11.6M |
|
|
MPG
495
DELISTED
Metaldyne Performance Group Inc.
MPG
| $11.8M | 0.01% |
559,773
-215,874
| -28% | -$4.24M |
|
|
FENX
496
DELISTED
Fenix Parts, Inc.
FENX
| $11.7M | 0.01% |
1,755,568
+573,747
| +49% | +$5.38M |
|
497
Seres Therapeutics
MCRB
$46.8M
| $11.6M | 0.01% |
19,585
+85
| +0.4% | +$69.3K |
|
498
Madrigal Pharmaceuticals
MDGL
$10.8B
| $11.5M | 0.01% |
189,208
+1,069
| +0.6% | +$77.1K |
|
|
EPRS
499
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
| $11.5M | 0.01% |
2,593,956
-36,986
| -1% | -$217K |
|
|
KIN
500
DELISTED
Kindred Biosciences, Inc.
KIN
| $11.3M | 0.01% |
2,173,893
+11,726
| +0.5% | +$72.3K |
|
Similar funds
Jennison Associates's Q3 2015 Portfolio in Review
As of Q3 2015, Jennison Associates held 813 positions worth $97.6B, down 11% from $109B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jennison Associates's Q3 2015 filing shows 84 new, 272 increased, 353 reduced and 92 closed positions. Its largest new stake was Palo Alto Networks: 12,124,434 shares worth $348M. The largest sale was Gilead Sciences, an estimated $722M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q3 2015 buy was Palo Alto Networks: 12,124,434 shares worth $348M.
- Jennison Associates added most to Alphabet (Google) Class C in Q3 2015, an estimated $820M increase.
- Jennison Associates's biggest Q3 2015 reduction was Gilead Sciences, cutting an estimated $722M.
- Jennison Associates fully exited KRAFT FOODS GROUP INC COM STK (VA) in Q3 2015, selling an estimated $144M.
- Jennison Associates's ten largest holdings make up 24% of its $97.6B portfolio in Q3 2015.
- Jennison Associates opened 84 new positions and closed 92 in Q3 2015.
- Jennison Associates's portfolio value fell 11% quarter-over-quarter to $97.6B.
Based on Jennison Associates's 13F filing for Q3 2015, filed 6 Nov 2015.